A record of what Anshul Saigal said publicly, with the source. Not advice.
Pending — not yet graded
“Bullish on the Pharma sector, particularly Contract Development and Manufacturing Organizations (CDMOs), viewing it as an attractive sector. The belief is that tariffs will positively impact India, making sectors like pharma more competitive and creating buying opportunities.”
Nifty PharmaBullishCalled 21 Apr 2025
This call has no verdict yet — it is graded HIT or MISS against real price data once a close decides it. Save it above to find it again from your profile.
Read the original articleSee Anshul Saigal’s full track record